Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1998
12/01/1998US5843963 Benzothiophene compounds, intermediates, processes, compositions, and methods
12/01/1998US5843960 Inhibitors of rotamase enzyme activity
12/01/1998US5843943 Compounds for inhibition of ceramide-mediated signal transduction
12/01/1998US5843940 Benzothiophene compounds, compositions, and method
12/01/1998US5843935 Protein kinase C inhibitors
12/01/1998US5843927 18,19-dinor-vitamin D compounds
12/01/1998US5843924 Intravenous alendronate formulations
12/01/1998US5843906 Meta-substituted phenylene sulphonamide derivatives
12/01/1998US5843904 Inhibitors of interleukin-1βconverting enzyme
12/01/1998US5843899 Use of insulin-like growth factors I and II for inhibition of inflammatory response
12/01/1998US5843894 Methods for reduced renal uptake of antibody fragments
12/01/1998US5843885 ICAM-1/LFA-1 short-chain peptides and method of using same
12/01/1998US5843883 Methods of wound healing and treating hyperproliferative diseases of epidermis comprising administering trunicated keratinocyte growh factor (KGF) having increased biological activity
12/01/1998US5843775 Human dorsal tissue affecting factor (noggin) and nucleic acids encoding same
12/01/1998US5843714 DNA encoding a novel human proteolipid
12/01/1998US5843688 Isolated tyrosinase derived peptides and uses thereof
12/01/1998US5843668 Human SQM1 protein homolog
12/01/1998US5843481 Treatment of proliferative disorders, metastasaes, and drug resistant tumors with vanadate compounds and derivatives or analogues thereof
12/01/1998US5843475 Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes
12/01/1998US5843438 Peripheralization of hematopoietic stem cells
12/01/1998US5843422 Method and compositions for treating injury
12/01/1998CA2022429C Methods and compositions for ameliorating the symptoms of sepsis
12/01/1998CA2016089C Salts of azelastine having improved solubility
12/01/1998CA2009593C Medicament containing dihydrolipoic acid as active substance
11/1998
11/30/1998CA2233554A1 Novel compounds
11/30/1998CA2233547A1 Histidine kinase
11/29/1998CA2233565A1 Novel compounds
11/29/1998CA2231723A1 Novel has2 splicing variant hoefc11: a target in chronic renal failure, inflammatory diseases and myocardial schemia
11/26/1998WO1998053079A1 Ubiquitin conjugation proteins
11/26/1998WO1998053068A1 Smad7 and uses thereof
11/26/1998WO1998053066A1 Smad2 phosphorylation and interaction with smad4
11/26/1998WO1998053065A1 Human semaphorin e and polynucleotides encoding it
11/26/1998WO1998053050A2 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998WO1998052973A1 New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
11/26/1998WO1998052965A1 20-ARALKYL-5α-PREGNANE DERIVATIVES
11/26/1998WO1998052963A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
11/26/1998WO1998052958A1 Human uncoupling protein 3
11/26/1998WO1998052948A1 Compounds for inhibition of ceramide-mediated signal transduction
11/26/1998WO1998052943A1 Indoline derivatives as 5ht2c receptor antagonists
11/26/1998WO1998052942A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
11/26/1998WO1998052941A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS
11/26/1998WO1998052940A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/26/1998WO1998052937A2 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
11/26/1998WO1998052935A1 Substituted heterocyclic compounds, method for preparing and compositions containing same
11/26/1998WO1998052934A1 METHOD FOR THE SYNTHESIS OF 8-C-β-D-[2'-O-(E)-CINNAMOYL] GLYCOPYRANOSYL-2-[2-HYDROXY] PROPYL-7-METHOXY-5-METHYLCHROMONE
11/26/1998WO1998052925A1 Analogs of duocarmycin and cc-1065
11/26/1998WO1998052915A2 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists
11/26/1998WO1998052910A1 Metalloproteinase inhibitors
11/26/1998WO1998052906A1 New nitromethyl ketones, process for preparing them and compositions containing them
11/26/1998WO1998052899A1 Polyhydroxybenzene derivatives and preventive/remedy for bone and cartilage diseases
11/26/1998WO1998052614A2 Composition and method for enhancing transport across biological membranes
11/26/1998WO1998052609A1 Sonodynamic therapy using an ultrasound sensitizer compound
11/26/1998WO1998052604A1 Therapeutic or prophylactic use of fibronectin-binding protein i (sfbi) as adjuvant
11/26/1998WO1998052598A1 Novel administration of thrombopoietin
11/26/1998WO1998052597A1 Apoptosis-inducing gelsolin sequences
11/26/1998WO1998052594A1 Compositions for enhancing immunosuppressants' pharmaceutical activities
11/26/1998WO1998052591A1 Glial cell line-derived neurotrophic factor receptors
11/26/1998WO1998052586A1 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease
11/26/1998WO1998052584A1 A method to increase the survival of transplanted cells
11/26/1998WO1998052577A1 Ganglioside gm3 induced apoptosis of neural cells
11/26/1998WO1998052573A1 Triterpene saponin analogs having adjuvant and immunostimulatory activity
11/26/1998WO1998052568A1 THE USE OF 1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE HETEROCYCLIC ANALOGUES FOR THE PREPARATION OF MEDICAMENTS USEFUL FOR THE TREATMENT OF CEREBROVASCULAR DISTURBANCES
11/26/1998WO1998052560A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject
11/26/1998WO1998052559A1 Raf kinase inhibitors
11/26/1998WO1998052553A1 Methods for treatment of conditions associated with lactosylceramide
11/26/1998WO1998041539A3 Secreted proteins and polynucleotides encoding them
11/26/1998WO1998036733A3 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/26/1998WO1998030582A3 Secreted proteins and polynucleotides encoding them
11/26/1998DE19722848A1 Leukotrien-B¶4¶-Derivate, insbesondere Oximo-LTB¶4¶-Antagonisten Leukotriene B¶4¶ derivatives, in particular oximo-LTB¶4¶ antagonists
11/26/1998CA2291477A1 Human semaphorin e and polynucleotides encoding it
11/26/1998CA2291169A1 Metalloproteinase inhibitors
11/26/1998CA2291123A1 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists
11/26/1998CA2291115A1 Substituted pyrazoles as p38 kinase inhibitors
11/26/1998CA2291111A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
11/26/1998CA2290831A1 New nitromethyl ketones, process for preparing them and compositions containing them
11/26/1998CA2290789A1 Analogs of duocarmycin and cc-1065
11/26/1998CA2290778A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
11/26/1998CA2290769A1 Ubiquitin conjugation proteins
11/26/1998CA2290721A1 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998CA2290657A1 A method to increase the survival of transplanted cells
11/26/1998CA2290598A1 Ganglioside gm3 induced apoptosis of neural cells
11/26/1998CA2290475A1 Indoline derivatives as 5ht2c receptor antagonists
11/26/1998CA2290426A1 Glial cell line-derived neurotrophic factor receptors
11/26/1998CA2290381A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject
11/26/1998CA2290040A1 Smad7 and uses thereof
11/26/1998CA2289945A1 Human uncoupling protein 3
11/26/1998CA2289906A1 Smad2 phosphorylation and interaction with smad4
11/26/1998CA2289847A1 The use of 1,2,4-triazolo¬1,5-c|pyrimidine heterocyclic analogues for the preparation of medicaments useful for the treatment of cerebrovascular disturbances
11/26/1998CA2289675A1 20-aralkyl-5.alpha.-pregnane derivatives
11/26/1998CA2288964A1 Novel administration of thrombopoietin
11/26/1998CA2288787A1 Pyrazole derivatives as p38 kinase inhibitors
11/26/1998CA2288741A1 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
11/26/1998CA2287484A1 Compounds for inhibition of ceramide-mediated signal transduction
11/25/1998EP0879889A2 A novel member of the IL-1 family, IL-1 delta
11/25/1998EP0879885A1 A novel human gene similar to a secreted murine protein sFRP-1
11/25/1998EP0879820A1 Benzamide analogues, useful as PARP (ADP-Ribosyltransferase, ADPRT) DNA repair enzyme inhibitors
11/25/1998EP0879605A2 Glycosyl prodrug conjugate with enhanced tolerance
11/25/1998EP0879602A1 A method to increase the survival of transplanted cells
11/25/1998EP0879596A2 Use of cholinesterase inhibitors to reduce benzodiazepine side effects
11/25/1998EP0879240A1 Human criptin growth factor
1 ... 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 ... 1564